TSLP is recognized as a crucial upstream driver of type 2 inflammation, and genetic variants leading to increased TSLP protein secretion have been associated with a higher risk of EGPA [17]. The gene discussed is TSLP; the disease is eosinophilic granulomatosis with polyangiitis.